XY Capital’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
104,130
+55,736
+115% +$705K 1.08% 18
2026
Q1
$724K Sell
48,394
-9,216
-16% -$135K 0.72% 30
2025
Q4
$768K Buy
57,610
+4,853
+9% +$70.9K 0.48% 43
2025
Q3
$831K Buy
52,757
+39,266
+291% +$646K 0.44% 56
2025
Q2
$203K Sell
13,491
-99,645
-88% -$1.46M 0.14% 38
2025
Q1
$1.7M Buy
113,136
+66,460
+142% +$983K 0.48% 46
2024
Q4
$673K Buy
+46,676
New +$834K 0.32% 77
2023
Q3
Sell
-26,515
Closed -$318K 150
2023
Q2
$318K Buy
26,515
+14,965
+130% +$204K 0.23% 80
2023
Q1
$150K Buy
11,550
+637
+6% +$10.4K 0.06% 94
2022
Q4
$161K Buy
+10,913
New +$119K 0.11% 66

Other funds holding HCM

XY Capital's HCM Position: Q2 2026 in Review

XY Capital increased its HUTCHMED (HCM) stake by 115% in Q2 2026, buying an estimated $705K and bringing the position to 104,130 shares worth $1.12M. The position accounts for 1.08% of the portfolio, ranked #18.

XY Capital first reported a position in HCM in Q4 2022 and has held it in 10 quarters since. The position peaked at $1.7M in Q1 2025. 56 funds tracked by Wall St. Rank hold HCM as of Q2 2026.

  • XY Capital held 104,130 shares of HUTCHMED worth $1.12M as of Q2 2026.
  • XY Capital bought 55,736 HUTCHMED shares in Q2 2026, an estimated $705K.
  • HUTCHMED made up 1.08% of XY Capital's portfolio in Q2 2026, its #18 holding.
  • XY Capital first reported a position in HUTCHMED in Q4 2022 and has held it in 10 quarters since.
  • XY Capital's HUTCHMED position peaked at $1.7M in Q1 2025.
  • 56 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2026.

Based on XY Capital's 13F filing for Q2 2026, filed 11 Aug 2026.